Effect of Relaxin in Two Models of Renal Mass Reduction

No abstract is available for this paper.

• Publication year

  2002

• Venue

  American Journal of Nephrology

• Publication date

  2002-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000066302PMID 12373075
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Relaxin decreases renal interstitial fibrosis and slows progression of renal disease.

  2001cited by this paper
• Systemic administration of recombinant human relaxin (RHRLX) ameliorates the acute cyclosporine nephrotoxicity in rats.

  2001cited by this paper
• Flow-induced pressure differentially regulates endothelin-1, urotensin II, adrenomedullin, and relaxin in pulmonary vascular endothelium.

  2001cited by this paper
• Relaxin inhibits effective collagen deposition by cultured hepatic stellate cells and decreases rat liver fibrosis in vivo

  2001cited by this paper
• The vasorelaxant hormone relaxin induces changes in liver sinusoid microcirculation: a morphologic study in the rat.

  2001cited by this paper
• Blockade of the renin-angiotensin and endothelin systems on progressive renal injury.

  2001cited by this paper
• Blockade of the Renin-Angiotensin and Endothelin Systems on Progressive Renal Injury

  2000cited by this paper
• Relaxin induces vascular endothelial growth factor expression and angiogenesis selectively at wound sites

  2000cited by this paper
• Functional and structural correlates of glomerulosclerosis after renal mass reduction in the rat.

  2000cited by this paper
• Impact of gender and endothelin on renal vasodilation and hyperfiltration induced by relaxin in conscious rats.

  2000cited by this paper
• Evaluation of a new fluorescent dye method to measure urinary albumin in lieu of urinary total protein.

  2000cited by this paper
• Quantitative autoradiographic studies of relaxin binding in rat atria, uterus and cerebral cortex: characterization and effects of oestrogen treatment

  1999cited by this paper
• Relaxin is a potent renal vasodilator in conscious rats.

  1999cited by this paper
• Angiotensin-converting enzyme inhibition reduces the effect of bromoethylamine-induced papillary necrosis and renal fibrosis.

  1998cited by this paper
• Relaxin: a pleiotropic hormone.

  1997cited by this paper
• Relaxin counteracts myocardial damage induced by ischemia-reperfusion in isolated guinea pig hearts: evidence for an involvement of nitric oxide.

  1997cited by this paper
• Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo.

  1996cited by this paper
• Relaxin‐induced increased coronary flow through stimulation of nitric oxide production

  1995cited by this paper
• Relaxin modulates synthesis and secretion of procollagenase and collagen by human dermal fibroblasts.

  1990cited by this paper
• The Physiology of reproduction

  1988cited by this paper
• Determination of serum creatinine by a direct colorimetric method.

  1973cited by this paper

• The renoprotective efficacy and safety of genetically-engineered human bone marrow-derived mesenchymal stromal cells expressing anti-fibrotic cargo

  2024cites this paper
• Enhancing the Therapeutic Potential of Mesenchymal Stromal Cell-Based Therapies with an Anti-Fibrotic Agent for the Treatment of Chronic Kidney Disease

  2022cites this paper
• Comparison of the Surgical Resection and Infarct 5/6 Nephrectomy Rat Models of Chronic Kidney Disease.

  2022cites this paper
• Relaxin Attenuates Organ Fibrosis via an Angiotensin Type 2 Receptor Mechanism in Aged Hypertensive Female Rats

  2021cites this paper
• Relaxin-mediated renal vasodilation in the rat is associated with falls in glomerular blood pressure.

  2018cites this paper
• Anti‐fibrotic actions of relaxin

  2017influential citation
• Novel Anti-fibrotic Therapies

  2017cites this paper
• Synthesis of recombinant human relaxin H2 in bacteria and its effects on differentiation of carcinoembryonic stem cells

  2017cites this paper
• The actions of relaxin on the human cardiovascular system

  2017cites this paper
• The Anti-fibrotic Actions of Relaxin Are Mediated Through a NO-sGC-cGMP-Dependent Pathway in Renal Myofibroblasts In Vitro and Enhanced by the NO Donor, Diethylamine NONOate

  2016influential citation
• Involvement of Cyclic Guanosine Monophosphate-Dependent Protein Kinase I in Renal Antifibrotic Effects of Serelaxin

  2016cites this paper
• Mesenchymal stromal cells targeting kidney disease: Benefits of a combined therapeutic approach

  2016cites this paper
• Angiotensin II Type 1 Receptor (AT1R) Changes in Animal Model of Chronic Kidney Disease: Evaluation and Pharmacotherapy

  2016cites this paper
• Identification of a rational, physiologically based early biomarker and pathogenic pathway for preeclampsia

  2016cites this paper
• Cyclic nucleotide signalling in kidney fibrosis

  2015cites this paper
• Relaxin-2 Does Not Ameliorate Nephropathy in an Experimental Model of Type-1 Diabetes

  2015cites this paper
• Combination therapy of mesenchymal stem cells and serelaxin effectively attenuates renal fibrosis in obstructive nephropathy

  2015cites this paper
• Renal Hemodynamic Effects of Serelaxin in Patients With Chronic Heart Failure: A Randomized, Placebo-Controlled Study

  2014cites this paper
• Relaxin: New Pathophysiological Aspects and Pharmacological Perspectives for an Old Protein

  2014cites this paper
• Therapeutic effects of serelaxin in acute heart failure.

  2014cites this paper
• DOTTORATO DI RICERCA IN SCIENZE BIOMEDICHE, INDIRIZZO IN MORFOLOGIA E MORFOGENESI UMANA

  2014cites this paper
• Activated omentum slows progression of CKD.

  2014cites this paper
• The emerging role of relaxin as a novel therapeutic pathway in the treatment of chronic kidney disease.

  2013cites this paper
• The anti-fibrotic hormone relaxin is not reno-protective, despite being active, in an experimental model of type 1 diabetes.

  2013cites this paper
• Relaxin ameliorates salt-sensitive hypertension and renal fibrosis.

  2012cites this paper
• Relaxin Ameliorates Hypertension and Increases Nitric Oxide Metabolite Excretion in Angiotensin II But Not N&ohgr;-Nitro-L-Arginine Methyl Ester Hypertensive Rats

  2011cites this paper
• Investigating the significance of relaxin in experimental diabetic renal disease

  2011influential citation
• Renal Tubulointerstitial Fibrosis Mechanism of Action in Experimental In Vivo Antifibrotic Properties of Relaxin

  2010cites this paper
• Antifibrotic properties of relaxin: in vivo mechanism of action in experimental renal tubulointerstitial fibrosis.

  2010cites this paper
• Common pathophysiological mechanisms of chronic kidney disease: therapeutic perspectives.

  2010cites this paper
• Relaxin: An Endogenous Renoprotective Factor?

  2009cites this paper
• [Surgical model of chronic renal failure: study in rabbits].

  2009cites this paper
• Scientific Rationale and Design of a Phase I Safety Study of Relaxin in Women with Severe Preeclampsia

  2009cites this paper
• Relaxin and its role in the development and treatment of fibrosis.

  2009cites this paper
• From molecules to medicine: a future cure for preeclampsia?

  2009cites this paper
• Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities?

  2009cites this paper
• Relaxin and the progression of kidney disease

  2009cites this paper
• Relaxin inhibits renal myofibroblast differentiation via RXFP1, the nitric oxide pathway, and Smad2

  2009cites this paper
• Relaxin and nitric oxide signalling.

  2008cites this paper
• Endogenous relaxin does not affect chronic pressure overload-induced cardiac hypertrophy and fibrosis.

  2008cites this paper
• Relaxin as a natural agent for vascular health

  2008cites this paper
• Relaxin ameliorates fibrosis in experimental diabetic cardiomyopathy.

  2008cites this paper
• Endogenous relaxin is a naturally occurring modulator of experimental renal tubulointerstitial fibrosis.

  2007cites this paper
• Pregnancy and Successful Full-Term Delivery in a Patient on Peritoneal Dialysis: One Center's Experience and Review of the Literature

  2007cites this paper
• Drugs of the future: the hormone relaxin

  2007cites this paper
• The effects of relaxin on extracellular matrix remodeling in health and fibrotic disease.

  2007cites this paper
• The vascular actions of relaxin.

  2007cites this paper
• Relaxin in cardiovascular and renal disease.

  2006cites this paper
• Glomerular epithelial cells transform to myofibroblasts: early but not late removal of TGF-beta1 reverses transformation.

  2006cites this paper
• Physiology and Molecular Biology of the Relaxin Peptide Family

  2006cites this paper
• Relaxin improves renal function and histology in aging Munich Wistar rats.

  2006cites this paper
• An emerging role for relaxin as a renal vasodilator.

  2006cites this paper
• Recombinant human relaxin reduces hypoxic pulmonary hypertension in the rat.

  2005cites this paper
• Relaxin: antifibrotic properties and effects in models of disease.

  2005cites this paper
• relaxin and the extracellular matrix: molecular mechanisms of action and implications for cardiovascular disease

  2005cites this paper
• Relaxin in vascular physiology and pathophysiology: possible implications in ischemic brain disease.

  2005cites this paper
• The Effect of Relaxin Treatment on Skeletal Muscle Injuries

  2005cites this paper
• Relaxin Reverses Cardiac and Renal Fibrosis in Spontaneously Hypertensive Rats

  2005cites this paper
• The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway.

  2005cites this paper
• New Insights into Biological Roles of Relaxin and Relaxin-related Peptides

  2005cites this paper
• Molecular Developments in the Treatment of Renal Fibrosis

  2005cites this paper
• The Relaxin Gene‐Knockout Mouse: A Model of Progressive Fibrosis

  2005cites this paper
• Relaxin down-regulates renal fibroblast function and promotes matrix remodelling in vitro.

  2004cites this paper
• Relaxin: new functions for an old peptide.

  2004cites this paper
• Relaxin-1-deficient mice develop an age-related progression of renal fibrosis.

  2004influential citation
• Emerging role of relaxin in renal and cardiovascular function.

  2004cites this paper
• Relaxin's physiological roles and other diverse actions.

  2004cites this paper
• Adenovirus-mediated expression of human prorelaxin promotes the invasive potential of canine mammary cancer cells.

  2003cites this paper
• Evaluation of Two Protocols of Uremic Rat Model: Partial Nephrectomy and Infarction

  2003cites this paper
• Time course and dose response of relaxin-mediated renal vasodilation, hyperfiltration, and changes in plasma osmolality in conscious rats.

  2003cites this paper
• Animal Remnant Kidney Model of Chronic Renal Failure Revisited

  2003cites this paper